Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.94 Insider Own0.10% Shs Outstand100.17M Perf Week-7.23%
Market Cap3.20B Forward P/E- EPS next Y-0.72 Insider Trans-73.79% Shs Float100.05M Perf Month-15.40%
Income-92.50M PEG- EPS next Q-0.27 Inst Own96.90% Short Float15.69% Perf Quarter3.26%
Sales0.10M P/S32014.33 EPS this Y-115.90% Inst Trans2.16% Short Ratio7.93 Perf Half Y24.31%
Book/sh3.18 P/B10.05 EPS next Y32.70% ROA-31.50% Target Price42.50 Perf Year38.90%
Cash/sh3.22 P/C9.93 EPS next 5Y20.00% ROE-32.50% 52W Range15.64 - 46.48 Perf YTD0.66%
Dividend- P/FCF- EPS past 5Y4.60% ROI-30.10% 52W High-31.24% Beta3.07
Dividend %- Quick Ratio20.50 Sales past 5Y-56.50% Gross Margin- 52W Low104.35% ATR2.13
Employees97 Current Ratio20.50 Sales Q/Q29.70% Oper. Margin- RSI (14)40.64 Volatility6.12% 5.73%
OptionableYes Debt/Eq0.00 EPS Q/Q-123.10% Profit Margin- Rel Volume1.10 Prev Close30.37
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout- Avg Volume1.98M Price31.96
Recom1.80 SMA20-12.69% SMA50-8.10% SMA20013.49% Volume2,172,878 Change5.24%
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Apr-11-13Reiterated Needham Buy $9 → $16
Apr-11-13Reiterated MLV & Co Buy $12.50 → $18
Apr-11-13Reiterated Ladenburg Thalmann Buy $9 → $15
Mar-13-13Reiterated Ladenburg Thalmann Buy $8 → $9
Nov-28-12Reiterated MLV & Co Buy $4.50 → $8.50
Nov-27-12Upgrade Needham Hold → Buy $9
Nov-27-12Reiterated Ladenburg Thalmann Buy $8
Apr-30-12Initiated Ladenburg Thalmann Buy
Sep-01-09Downgrade Citigroup Hold → Sell
May-05-09Upgrade JMP Securities Mkt Perform → Mkt Outperform $7
Aug-06-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-08-08Upgrade Banc of America Sec Sell → Neutral
Jun-17-08Downgrade Jefferies & Co Buy → Hold $14 → $4
Mar-27-15 09:00PM  IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against ACADIA Pharmaceuticals Inc. in the United States District Court for the Southern District of Californi GlobeNewswire +5.24%
Mar-26-15 08:28AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors at noodls
08:00AM  ACADIA Pharmaceuticals Appoints Daniel Soland to Board of Directors Business Wire
06:05AM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K/A, Change in Directors or Principal Officers
Mar-25-15 05:04PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or -7.28%
03:45PM  Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capitals Latest Moves in Healthcare Sector at Insider Monkey
01:07PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD Marketwired
12:32PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In ACADIA Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Mar-24-15 07:30PM  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals, Inc. -- ACAD GlobeNewswire
Mar-23-15 08:30AM  Hagens Berman Alerts ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD) Investors With Over $100,000 in Losses of May 12th Lead Plaintiff Deadline GlobeNewswire
Mar-20-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. Business Wire
Mar-19-15 09:30AM  The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases
Mar-18-15 12:44PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Acadia Pharmaceuticals, Inc. (ACAD) to Contact the Firm Marketwired
10:49AM  Biotech Stock Roundup: Amgen & Regeneron Shine at ACC, Nektar Drug Disappoints - Analyst Blog
10:00AM  ACADIA Pharmaceuticals Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
09:45AM  Deadline in Lawsuit for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Announced by Shareholders Foundation GlobeNewswire
Mar-17-15 08:45PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in ACADIA Pharmaceuticals Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- ACAD GlobeNewswire
06:38PM  Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ACADIA Pharmaceuticals Inc. PR Newswire
10:26AM  Morgan & Morgan Announces That a Class Action Lawsuit Was Filed Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
Mar-16-15 10:00PM  ACADIA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. -- ACAD GlobeNewswire
07:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ACADIA Pharmaceuticals Inc. and Certain Officers -- ACAD GlobeNewswire
02:15PM  INVESTOR ALERT: Investigation of ACADIA Pharmaceuticals Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
12:28PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ACADIA PHARMACEUTICALS INC. of PENDENCY OF CLASS ACTION Lawsuit and a Lead Plaintiff DEADLINE of May 12, 2015 -- ACAD GlobeNewswire
10:01AM  Acadia Pharmaceuticals Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing PR Newswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
Mar-13-15 10:00PM  Robbins Geller Rudman & Dowd LLP Files Class Action Suit against ACADIA Pharmaceuticals Inc. Business Wire
08:48PM  Lightning Round: Time to take profits on this at CNBC
08:14PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders PR Newswire
04:25PM  ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Acadia Pharmaceuticals, Inc. (ACAD) To Contact The Firm PR Newswire
01:24PM  Nasdaq stocks posting largest percentage decreases
08:50AM  ACADIA Pharmaceuticals (ACAD) Crumbles: Stock Falls by 22.2% - Tale of the Tape
Mar-12-15 08:10PM  Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc. PR Newswire -22.21%
06:04PM  Most active Nasdaq-traded stocks
05:03PM  Citigroup and Intel are big market movers
04:15PM  CFO Moves: Dollar General, ACADIA Pharmaceuticals, Endologix at The Wall Street Journal
03:14PM  ACAD SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by Acadia Pharmaceuticals Inc. Business Wire
01:56PM  Acadia Pharma Tumbles On Drug Delay, CEO Departure at Investor's Business Daily
01:08PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD PR Newswire
12:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acadia Pharmaceuticals Inc. PR Newswire
11:25AM  U.S. stocks rebound as rate-hike fear, dollars surge ease at MarketWatch
11:12AM  US stocks lifted by financials as dollar dips
11:11AM  Acadia Pharmaceuticals (ACAD) Stock Tanks Today on Delayed Regulatory Application at TheStreet
10:40AM  US open: Dow gains over 170 points as dollar's rally slows down
09:05AM  Shake Shack shakedown; Lumber Liquidators repairs rep; Krispy Kreme gets dunked
08:04AM  Early movers: SHAK, BOX, DG, HPQ, UTX, LL & more at CNBC
08:02AM  Bulls push back as dollar rally fades; Retail sales fall again; Mattel's "creepy" Barbie
Mar-11-15 08:52PM  US pre-open: Futures point to mixed open as dollar's surge loses momentum Sharecast
04:39PM  Acadia Drug Is Delayed Again as CEO Announces Retirement at TheStreet
04:35PM  Acadia shares drop 22% on drug delay, CEO departure at MarketWatch
04:28PM  Acadia Pharma tanks on sudden CEO retirement at CNBC
04:24PM  Acadia delays U.S. application to market lead drug, CEO retires Reuters
04:02PM  ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Business Wire
04:01PM  ACADIA Pharmaceuticals Updates Planned Timing of NUPLAZIDTM NDA Submission Business Wire
01:38PM  Nasdaq stocks posting largest percentage increases AP
01:01PM  Acadia's Absence Makes Hearts Grow Fonder at The Wall Street Journal
Mar-10-15 07:00PM  ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks at Insider Monkey +17.85%
05:03PM  Stocks End At Session Lows; Habit Down After Hours at Investor's Business Daily
02:51PM  Acadia Rises as Canceled Events Cause Deal Speculation at Bloomberg
Feb-27-15 07:37PM  Cramer Remix: Look for this from Warren Buffett at CNBC
07:01PM  Lightning Round: Beware of this happening in March at CNBC
Feb-26-15 07:22PM  Acadia reports 4Q loss AP
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:07PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014 Business Wire
07:07AM  Q4 2014 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Feb-25-15 11:00AM  Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog Zacks
08:54AM  Is a Surprise Coming for ACADIA Pharmaceuticals (ACAD) This Earnings Season? - Tale of the Tape Zacks
Feb-24-15 04:10PM  Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog Zacks
03:40PM  Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog Zacks
12:20PM  Will Allscripts (MDRX) Surprise Earnings Estimates in Q4? - Analyst Blog Zacks
09:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
07:05AM  Coverage initiated on ACADIA Pharmaceuticals by H.C. Wainwright Briefing.com
Feb-23-15 05:48PM  10 stocks that are pushing the Nasdaq to 5,000 at MarketWatch
12:10PM  Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog Zacks
Feb-20-15 11:20AM  Can Greatbatch (GB) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
11:10AM  Ecolab's (ECL) Q4 Earnings: Will it Disappoint Estimates? - Analyst Blog Zacks
Feb-19-15 09:00AM  ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015 Business Wire
08:38AM  Can the Uptrend Continue for ACADIA Pharmaceuticals (ACAD)? - Tale of the Tape Zacks
Feb-18-15 10:35AM  Will Patterson Companies (PDCO) Earnings Disappoint in Q4? - Analyst Blog Zacks
Feb-17-15 02:40PM  Will Community Health Systems (CYH) Q4 Earnings Miss? - Analyst Blog Zacks
Feb-09-15 11:00AM  Will CVS Health's (CVS) Earnings Surprise this Season? - Analyst Blog Zacks
Feb-06-15 12:39PM  Cushman & Wakefield: REITs Will Continue to Rock in 2015 And Which Ones to Buy at TheStreet
Feb-04-15 09:58AM  Myriad Genetics Q2 Earnings, Revenues Beat; Fall Y/Y - Analyst Blog Zacks
Jan-30-15 05:13PM  Intercept absolutely a buy: Pro CNBC
02:20PM  Qiagen (QGEN) Disappoints with Q4 Earnings, Revenue Miss - Analyst Blog Zacks
Jan-28-15 02:30PM  Street Talk: NOV, UPL, PKG, ACAD & MRCY CNBC
Jan-06-15 09:00AM  ACADIA Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 13, 2015 Business Wire
Dec-23-14 11:17AM  Biotech Bull Markets and Billion-Dollar Valuations Yahoo Finance Contributors -6.42%
Dec-12-14 08:38PM  [video]Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan at TheStreet
Dec-08-14 09:00AM  ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinsons Disease and Related Disorders Business Wire
Nov-25-14 09:00AM  ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
Nov-19-14 04:09PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
01:04PM  ACADIA PHARMACEUTICALS INC Financials EDGAR Online Financials
Nov-13-14 09:00AM  ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014 Business Wire
Nov-12-14 07:09PM  10-Q for ACADIA Pharmaceuticals, Inc. Company Spotlight
Nov-10-14 05:13PM  Acadia misses 3Q profit forecasts AP
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:01PM  ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID NDA Submission Business Wire
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis; is in Phase II study for Alzheimer's disease psychosis; and has completed Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hacksell UliCEOFeb 17Option Exercise1.5530,00046,50030,000Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Option Exercise4.9019,84797,20128,347Feb 19 06:00 PM
Hacksell UliCEOFeb 17Sale34.3030,0001,028,868115,549Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Sale35.0519,847695,5448,500Feb 19 06:00 PM
Brege LauraDirectorFeb 11Option Exercise1.7510,00017,50010,000Feb 13 05:57 PM
Brege LauraDirectorFeb 11Sale33.6310,000336,3490Feb 13 05:57 PM
BORER MICHAEL TDirectorJan 15Option Exercise11.8227,973330,59227,973Jan 16 05:52 PM
BORER MICHAEL TDirectorJan 15Sale33.0227,973923,7660Jan 16 05:52 PM
Hacksell UliCEOJan 14Option Exercise2.0030,00060,00030,000Jan 16 05:51 PM
Hacksell UliCEOJan 14Sale33.9830,0001,019,430115,549Jan 16 05:51 PM
GRAY MARY ANNDirectorJan 13Option Exercise11.004,25046,7504,250Jan 15 06:02 PM
Rasmussen TorstenDirectorJan 13Option Exercise11.0611,905131,66720,405Jan 15 06:03 PM
Rasmussen TorstenDirectorJan 13Sale35.0011,905416,6768,500Jan 15 06:03 PM
GRAY MARY ANNDirectorJan 13Sale35.004,250148,7500Jan 15 06:02 PM
Hacksell UliCEODec 15Option Exercise2.0030,00060,00030,000Dec 17 05:37 PM
GRAY MARY ANNDirectorDec 15Option Exercise9.4512,250115,78012,250Dec 17 05:38 PM
GRAY MARY ANNDirectorDec 15Sale31.7412,250388,8150Dec 17 05:38 PM
Hacksell UliCEODec 15Sale31.0030,000929,916115,549Dec 17 05:37 PM
Baity GlennEVP AND GCDec 09Option Exercise1.558,00012,40062,423Dec 10 06:53 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Option Exercise0.0025,000043,550Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Option Exercise11.0015,000165,00015,000Nov 26 06:29 PM
Mills RogerEVP, DEVELOPMENT AND CMONov 26Sale30.0925,000752,26518,550Nov 26 06:29 PM
BORER MICHAEL TDirectorNov 26Sale30.0515,000450,7650Nov 26 06:29 PM
Hacksell UliCEONov 24Option Exercise2.0030,00060,00030,000Nov 26 06:27 PM
Hacksell UliCEONov 24Sale29.2830,000878,397115,549Nov 26 06:27 PM
Wells William McDowallDirectorNov 21Option Exercise1.365,8107,9025,810Nov 21 07:48 PM
Wells William McDowallDirectorNov 21Sale29.005,810168,4900Nov 21 07:48 PM
Hacksell UliCEOOct 08Option Exercise2.0030,00060,00030,000Oct 10 05:30 PM
Hacksell UliCEOOct 08Sale24.1530,000724,530115,549Oct 10 05:30 PM
Brege LauraDirectorSep 15Option Exercise1.7510,00017,50010,000Sep 16 06:05 PM
Brege LauraDirectorSep 15Sale28.0710,000280,6690Sep 16 06:05 PM
Wells William McDowallDirectorSep 12Option Exercise1.369,19012,4989,190Sep 16 06:04 PM
Wells William McDowallDirectorSep 12Sale29.159,190267,8730Sep 16 06:04 PM
Hacksell UliCEOSep 10Option Exercise2.0030,00060,00030,000Sep 12 05:56 PM
Hacksell UliCEOSep 10Sale27.3630,000820,821115,549Sep 12 05:56 PM
Wells William McDowallDirectorSep 02Option Exercise1.3630,00040,80030,000Sep 04 06:06 PM
KAPLAN LESTER J PH DDirectorSep 02Option Exercise1.3057,69275,00066,192Sep 04 06:11 PM
Wells William McDowallDirectorSep 02Sale26.8830,000806,4000Sep 04 06:06 PM
KAPLAN LESTER J PH DDirectorSep 02Sale26.7657,6921,543,8388,500Sep 04 06:11 PM
Hacksell UliCEOAug 15Option Exercise6.8615,000102,90015,000Aug 15 05:44 PM
Hacksell UliCEOAug 15Sale22.8915,000343,371115,549Aug 15 05:44 PM
Hacksell UliCEOJul 14Option Exercise6.8620,000137,20020,000Jul 16 06:00 PM
Hacksell UliCEOJul 14Sale22.2220,000444,374115,549Jul 16 06:00 PM
Hacksell UliCEOJun 16Option Exercise6.8620,000137,20020,000Jun 18 05:59 PM
Hacksell UliCEOJun 16Sale23.1020,000462,004115,549Jun 18 05:59 PM
Wells William McDowallDirectorJun 09Option Exercise1.6015,00024,00015,000Jun 10 06:08 PM
Wells William McDowallDirectorJun 09Sale23.0315,000345,4560Jun 10 06:08 PM
Rasmussen TorstenDirectorMay 01Option Exercise10.4632,857343,75341,357May 02 06:01 PM
Rasmussen TorstenDirectorMay 01Sale20.0332,857658,2348,500May 02 06:01 PM
Hacksell UliCEOApr 15Option Exercise6.9525,000173,75025,000Apr 17 06:00 PM
Hacksell UliCEOApr 15Sale17.7525,000443,835115,549Apr 17 06:00 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Option Exercise1.557,50011,62538,848Apr 04 07:51 PM
Rasmussen TorstenDirectorApr 04Option Exercise2.4030,00072,07538,500Apr 04 07:52 PM
Brege LauraDirectorApr 04Option Exercise1.7514,28524,99914,285Apr 04 07:52 PM
Brege LauraDirectorApr 04Sale22.5414,285321,9250Apr 04 07:52 PM
Rasmussen TorstenDirectorApr 04Sale21.9830,000659,3858,500Apr 04 07:52 PM
Aasen Thomas HEXEC VP, CFO AND CBOApr 04Sale22.4815,000337,2600Apr 04 07:51 PM